ChromaDex (OTCBB: CDXC), today announced that it has entered into an exclusive agreement with Cargill (Wayzata, Minn.) to supply global analytical reference standards and research materials for the individual sweet components of stevia. This provides the ability for food and beverage companies to validate rebiana for use in consumer products.
With the introduction of TruviaTM rebiana natural sweetener by Cargill, there is a need to insure the quality of stevia related products. These new analytical reference methods will provide that industry standards set for rebiana meet specifications of consistency and quality. Rebiana is a natural product originating with the leaves of the stevia plant. Previously, there were no accepted standards of identity for food and beverage companies to use to evaluate stevia-based products.
ChromaDex and Cargill have partnered to create the quality assurance and research tools necessary for analytical testing of stevia based products, from raw material to finished sweeteners such as rebiana.
“We are very pleased to be partnering with Cargill,” said Frank Jaksch, CEO and co-founder of ChromaDex, Inc. “Not all stevia sweeteners are created equal, and it will be important for companies using stevia ingredients to select the right standards and analytical methods in differentiating products that meet requirements for food use. By partnering with Cargill, ChromaDex now offers an extensive range of stevia-related sweet compounds as analytical reference standards or research materials.”
“Cargill has a long history and an established reputation for providing high quality food ingredients to customers globally,” said Zanna McFerson, business director TruviaTM natural sweetener. “For rebiana, we not only developed the specifications for this new sweetener, but we also created the methods and systems to insure that our product is consistent each and every time for our customers and consumers.”
ChromaDex is a world leader in the development of Phytochemical and Botanical Reference Standards. ChromaDex provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools, products and services to meet the regulatory, quality, efficacy and safety standards for their products.
Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to those relating to product and customer demand, market acceptance of our products, the effect of economic conditions both nationally and internationally, ability to protect our intellectual property rights, impact of any litigation or infringement actions brought against us, competition from other providers and products, risks in product development, our ability to raise capital to fund continuing operations, the ability to complete transactions, and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.